Perspective Therapeutics Inc (CATX) Stock Price, Quote & News

Company Profile

Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. It discovers and develops its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a b...

Industry: Medical Devices

Sector: Healthcare

Phone: 206 676 0900

Website: www.perspectivetherapeutics.com

Address:

2401 Elliott Avenue, Suite 320, Seattle, United States

drdenturedds Jun. 4 at 11:43 PM

$CATX This is just my humble opinion but I think that what we saw today was Morgan Stanley dumping the rest of their shares today. According to fintel.io they had roughly 3 million shares left after dumping roughly 1.5 million shares in the most recent reporting period.

0 · Reply

Hoosiers01 Jun. 4 at 9:24 PM

$CATX - hmmm … stocks up + 874 points - can’t make this up - ISR / CATX $ .32 - a few weeks ago I said $1.67 coming up or $.16 and tell me or show me I’m wrong -

0 · Reply